Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117855894 | 11785589 | 4 | F | 20151120 | 20160628 | 20151130 | 20160706 | EXP | US-AMGEN-USASL2015124249 | AMGEN | 70.00 | YR | E | F | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117855894 | 11785589 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | 1059551 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 117855894 | 11785589 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 117855894 | 11785589 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117855894 | 11785589 | 1 | Psoriatic arthropathy |
| 117855894 | 11785589 | 2 | Product used for unknown indication |
| 117855894 | 11785589 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117855894 | 11785589 | HO |
| 117855894 | 11785589 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117855894 | 11785589 | Arthropathy | |
| 117855894 | 11785589 | Cerebrovascular accident | |
| 117855894 | 11785589 | Feeling abnormal | |
| 117855894 | 11785589 | Fibromyalgia | |
| 117855894 | 11785589 | Finger deformity | |
| 117855894 | 11785589 | Grip strength decreased | |
| 117855894 | 11785589 | Immune system disorder | |
| 117855894 | 11785589 | Injection site erythema | |
| 117855894 | 11785589 | Injection site haemorrhage | |
| 117855894 | 11785589 | Injection site pain | |
| 117855894 | 11785589 | Injection site pruritus | |
| 117855894 | 11785589 | Mobility decreased | |
| 117855894 | 11785589 | Muscle spasms | |
| 117855894 | 11785589 | Muscle tightness | |
| 117855894 | 11785589 | Musculoskeletal discomfort | |
| 117855894 | 11785589 | Musculoskeletal stiffness | |
| 117855894 | 11785589 | Myalgia | |
| 117855894 | 11785589 | Psoriasis | |
| 117855894 | 11785589 | Puncture site haemorrhage | |
| 117855894 | 11785589 | Skin burning sensation | |
| 117855894 | 11785589 | Somnolence | |
| 117855894 | 11785589 | Spinal laminectomy | |
| 117855894 | 11785589 | Spondylitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117855894 | 11785589 | 1 | 2009 | 0 |